PharmGen Science, Inc. (KRX:004720)
South Korea
· Delayed Price · Currency is KRW 4,475.00
+65.00 (1.47%)
Last updated: Jun 9, 2025
PharmGen Science Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 171,658 | 171,287 | 166,779 | 150,931 | 109,866 | 96,614 | Upgrade
|
| Other Revenue | -0 | -0 | - | - | -0 | - | Upgrade
|
| Revenue | 171,658 | 171,287 | 166,779 | 150,931 | 109,866 | 96,614 | Upgrade
|
| Revenue Growth (YoY) | -0.02% | 2.70% | 10.50% | 37.38% | 13.72% | 1.55% | Upgrade
|
| Cost of Revenue | 63,303 | 63,413 | 69,029 | 69,857 | 49,136 | 43,085 | Upgrade
|
| Gross Profit | 108,356 | 107,874 | 97,749 | 81,073 | 60,730 | 53,529 | Upgrade
|
| Selling, General & Admin | 91,609 | 90,112 | 81,752 | 69,089 | 61,822 | 50,270 | Upgrade
|
| Research & Development | 4,370 | 4,402 | 5,118 | 2,886 | 2,270 | 1,115 | Upgrade
|
| Other Operating Expenses | 177.62 | 163.82 | 206.93 | 203.02 | 175.86 | 109.92 | Upgrade
|
| Operating Expenses | 98,697 | 97,248 | 88,623 | 73,662 | 65,668 | 55,434 | Upgrade
|
| Operating Income | 9,658 | 10,626 | 9,127 | 7,412 | -4,938 | -1,905 | Upgrade
|
| Interest Expense | -4,157 | -4,157 | -4,264 | -3,509 | -1,721 | -289.55 | Upgrade
|
| Interest & Investment Income | 100 | 100 | 98.41 | 66.04 | 87.8 | 119.67 | Upgrade
|
| Earnings From Equity Investments | -7,355 | -4,916 | -2,539 | 87,213 | 46,633 | 14,508 | Upgrade
|
| Currency Exchange Gain (Loss) | 2.13 | 2.13 | 217.94 | 13.97 | 0.2 | -24.05 | Upgrade
|
| Other Non Operating Income (Expenses) | 2,591 | 2,440 | 5,938 | -1,115 | 2,699 | -31.05 | Upgrade
|
| EBT Excluding Unusual Items | 839.99 | 4,095 | 8,579 | 90,081 | 42,760 | 12,378 | Upgrade
|
| Gain (Loss) on Sale of Investments | -3,061 | -3,061 | 51.6 | 9.77 | 1.11 | -1,085 | Upgrade
|
| Gain (Loss) on Sale of Assets | -16.83 | -16.83 | 46.35 | 2.94 | -11.49 | -29.13 | Upgrade
|
| Asset Writedown | - | - | -228.3 | -133.08 | -799.9 | -53.75 | Upgrade
|
| Pretax Income | -2,238 | 1,017 | 8,448 | 89,960 | 41,949 | 11,209 | Upgrade
|
| Income Tax Expense | -2,370 | -1,773 | 2,361 | 19,902 | 9,535 | 2,085 | Upgrade
|
| Earnings From Continuing Operations | 131.91 | 2,790 | 6,088 | 70,058 | 32,414 | 9,124 | Upgrade
|
| Minority Interest in Earnings | -14.16 | 1.05 | 1.04 | 1.48 | 51.54 | 98.12 | Upgrade
|
| Net Income | 117.75 | 2,791 | 6,089 | 70,060 | 32,466 | 9,222 | Upgrade
|
| Net Income to Common | 117.75 | 2,791 | 6,089 | 70,060 | 32,466 | 9,222 | Upgrade
|
| Net Income Growth | -98.21% | -54.16% | -91.31% | 115.79% | 252.04% | 2953.92% | Upgrade
|
| Shares Outstanding (Basic) | 18 | 18 | 16 | 16 | 15 | 14 | Upgrade
|
| Shares Outstanding (Diluted) | 21 | 22 | 21 | 22 | 19 | 15 | Upgrade
|
| Shares Change (YoY) | 0.11% | 4.74% | -3.68% | 16.09% | 23.81% | 30.15% | Upgrade
|
| EPS (Basic) | 6.50 | 153.88 | 374.22 | 4498.10 | 2206.02 | 674.98 | Upgrade
|
| EPS (Diluted) | 6.50 | 152.25 | 323.65 | 3369.29 | 1814.33 | 623.34 | Upgrade
|
| EPS Growth | -98.08% | -52.96% | -90.39% | 85.70% | 191.07% | 2297.46% | Upgrade
|
| Free Cash Flow | -1,940 | 1,466 | 3,173 | -11,208 | -22,966 | -1,664 | Upgrade
|
| Free Cash Flow Per Share | -91.07 | 67.29 | 152.58 | -519.12 | -1234.84 | -110.74 | Upgrade
|
| Gross Margin | 63.12% | 62.98% | 58.61% | 53.72% | 55.28% | 55.41% | Upgrade
|
| Operating Margin | 5.63% | 6.20% | 5.47% | 4.91% | -4.49% | -1.97% | Upgrade
|
| Profit Margin | 0.07% | 1.63% | 3.65% | 46.42% | 29.55% | 9.54% | Upgrade
|
| Free Cash Flow Margin | -1.13% | 0.86% | 1.90% | -7.43% | -20.90% | -1.72% | Upgrade
|
| EBITDA | 14,286 | 15,262 | 13,374 | 10,783 | -1,796 | 1,057 | Upgrade
|
| EBITDA Margin | 8.32% | 8.91% | 8.02% | 7.14% | -1.64% | 1.09% | Upgrade
|
| D&A For EBITDA | 4,628 | 4,636 | 4,247 | 3,371 | 3,142 | 2,963 | Upgrade
|
| EBIT | 9,658 | 10,626 | 9,127 | 7,412 | -4,938 | -1,905 | Upgrade
|
| EBIT Margin | 5.63% | 6.20% | 5.47% | 4.91% | -4.49% | -1.97% | Upgrade
|
| Effective Tax Rate | - | - | 27.94% | 22.12% | 22.73% | 18.60% | Upgrade
|
| Advertising Expenses | - | 2,284 | 2,345 | 2,833 | 2,168 | 1,853 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.